4/30/2024 | BKCVDDEMIGPV | Market Commentary: Euro junk primary on fire; Iliad strong on break; U.S. Acute Care, Harvest Midstream fade
|
4/30/2024 | HY | Market Commentary: Euro junk primary on fire; Iliad strong on break; U.S. Acute Care, Harvest Midstream fade
|
4/29/2024 | BKCVDDEMIGPV | Market Commentary: U.S. Acute Care, Harvest Midstream price; Iliad on deck; Citrix levels
|
4/29/2024 | HY | Market Commentary: U.S. Acute Care, Harvest Midstream price; Iliad on deck; Citrix levels
|
4/29/2024 | HY | New Issue: U.S. Acute Care Solutions prices $800 million five-year secured notes at 98.071 to yield 10¼%
|
4/29/2024 | BKHY | S&P assigns B- to U.S. Acute Care revolver, notes
|
4/29/2024 | HY | U.S. Acute Care talks $800 million five-year secured notes to yield 10%-10¼%; pricing Monday
|
4/29/2024 | BKHY | Moody's assigns B3 to U.S. Acute Care notes
|
4/29/2024 | HY | U.S. Acute Care to price $800 million five-year secured notes; early guidance 10¼% yield
|
4/29/2024 | BK | U.S. Acute Care to pay down revolver drawings with notes proceeds
|
11/17/2023 | BKCVDDEMIGPV | Market Commentary: Junk prices $2.1 billion, eyes busy December; Fortress lags; Gap gains; Acute Care tumbles
|
11/17/2023 | HY | Market Commentary: Junk prices $2.1 billion, eyes busy December; Fortress lags; Gap gains; Acute Care tumbles
|
11/17/2023 | HY | Market Commentary: U.S. Acute Care declines; Community Health notes jump; Enviva bonds extend losses
|
11/17/2023 | DD | Market Commentary: U.S. Acute Care paper declines; Community Health notes jump; Enviva bonds extend losses
|
9/27/2023 | BKHY | Moody’s lowers U.S. Acute Care
|
1/19/2022 | BKCVDDEMIGPV | Market Commentary: Builders FirstSource, US Acute Care add on in junkland; GrubHub gains; Golden Nugget loses
|
1/19/2022 | HY | Market Commentary: Builders FirstSource, US Acute Care add on in junkland; GrubHub gains; Golden Nugget loses
|
1/19/2022 | HY | New Issue: US Acute Care Solutions prices $225 million tap of 6 3/8% notes due 2026 at 101.5
|
1/19/2022 | HY | US Acute Care driving by with $225 million tap of 6 3/8% notes; initial price talk 100-101
|
8/16/2021 | HY | New Issue: U.S. Acute Care Solutions prices $125 million tap of 6 3/8% notes due 2026 at 103
|
8/16/2021 | HY | U.S. Acute Care Solutions to price $125 million tap of 6 3/8% notes due 2026 on Monday
|
2/25/2021 | HY | Market Commentary: Primary raises $3.32 billion; secondary under pressure; Post flat; TopBuild, TTM trade up
|
2/25/2021 | HY | New Issue: US Acute Care Solutions prices $375 million 6 3/8% five-year secured notes at par
|
2/25/2021 | HY | US Acute Care Solutions talks $375 million five-year secured notes at 6½% area; pricing Thursday
|
2/24/2021 | HY | Moody’s gives U.S. Acute Care, notes B2
|
2/24/2021 | HY | US Acute Care on roadshow for $375 million five-year secured notes; initial talk mid-6% area
|